Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline anti-human IL-23p19 antibodies

Crystalline anti-human IL-23p19 antibodies

US Patent 9803010 · Granted Oct 31, 2017

Estimated economic value: $123,750,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solution formulations of engineered anti-IL-23p19 antibodies2025
Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods2023
Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods2023
Factor XIIa inhibitors2021
Crystals of anti-human PD-1 monoclonal antibodies2021
Crystals of anti-human PD-1 monoclonal antibodies2021
Crystals of anti-human PD-1 monoclonal antibodies2021
Factor XIIa inhibitors2020
Anti-CD27 antibodies2020
Engineered anti-IL-23p19 antibodies2017
Albumin-free factor VIII formulations2017
Liquid formulations for TNFR:Fc fusion proteins2017